- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Over 2,000 real rulings — analysed for what they mean to your team. Published every day.
Showing 1914 cases
At a GP meeting, a Meda rep detailed Dymista without proactively stating it was locally ‘grey listed’. PMCPA found the omission misleading…
Complaint about an online Spiolto COPD ad: missing generic name for Spiriva, unclear comparator device, and missing/outdated PI and references. Panel found…
A rep read an in-call statement implying a CCG-backed commercial agreement meant Symbicort cost wasn’t a barrier. The statement lacked patient-scope limits,…
Complaint about Emerade’s claimed 30‑month shelf-life versus shorter expiry supplied by a pharmacy. Panel found the complainant hadn’t shown the claims were…
Shield’s corporate site contained publicly accessible promotional content for Feraccru and promotional descriptions of unlicensed pipeline products. PMCPA found multiple breaches including…
A pharmacist complained GSK’s Seretide TORCH mortality exhibition panel highlighted a 16.5% risk reduction (p=0.096). PMCPA ruled it didn’t make non-significance clear…
Gilead’s Truvada BICOMBO leavepieces implied superiority and overstated lipid benefits without clinical context and without reflecting SPC safety info. Breaches of Clauses…
Anonymous complaint alleged Lilly-sponsored Heathrow meeting was a social get-together with music/cultural programme. Panel had due diligence concerns but found no evidence…
A Tabphyn MR journal ad claimed “Spend fewer pennies on the treatment of BPH”. PMCPA ruled it a hanging comparison (breach Clause…
A Versatis budget impact brochure compared “Total NHS cost” vs gabapentin but didn’t clearly define what costs were included. The PMCPA found…
A practice manager alleged a Teva rep was aggressive, demanded an immediate meeting and implied patients would suffer if advice wasn’t followed.…
A PCT pharmacist complained GSK promoted Rotarix to practice nurses (non-prescribers). PMCPA found it reasonable given nurses’ role in vaccine administration/ordering and…
A consultant challenged an MSD-commissioned market research survey that asked HCPs to nominate other specialists. Panel had concerns (transparency on questionnaire, £25…
PMCPA review of Vifor Fresenius clinical trial disclosure for Velphoro was found outwith the scope of the 2016 ABPI Code. No breach…
Complaint about omission of prescribing information/obligatory information. PMCPA concluded no breach and that the matter was outwith the scope of the ABPI…
Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases — ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week — free.